Matches in Wikidata for { <http://www.wikidata.org/entity/Q94146087> ?p ?o ?g. }
Showing items 1 to 69 of
69
with 100 items per page.
- Q94146087 description "article scientifique publié en 2018" @default.
- Q94146087 description "wetenschappelijk artikel" @default.
- Q94146087 description "наукова стаття" @default.
- Q94146087 name "ATIM-26. IMMUNOLOGIC TRENDS ASSOCIATED WITH PATIENT OUTCOMES IN A PHASE 1 CLINICAL TRIAL OF TOCA 511 AND TOCA FC IN RECURRENT HIGH GRADE GLIOMA" @default.
- Q94146087 name "ATIM-26. IMMUNOLOGIC TRENDS ASSOCIATED WITH PATIENT OUTCOMES IN A PHASE 1 CLINICAL TRIAL OF TOCA 511 AND TOCA FC IN RECURRENT HIGH GRADE GLIOMA" @default.
- Q94146087 type Item @default.
- Q94146087 label "ATIM-26. IMMUNOLOGIC TRENDS ASSOCIATED WITH PATIENT OUTCOMES IN A PHASE 1 CLINICAL TRIAL OF TOCA 511 AND TOCA FC IN RECURRENT HIGH GRADE GLIOMA" @default.
- Q94146087 label "ATIM-26. IMMUNOLOGIC TRENDS ASSOCIATED WITH PATIENT OUTCOMES IN A PHASE 1 CLINICAL TRIAL OF TOCA 511 AND TOCA FC IN RECURRENT HIGH GRADE GLIOMA" @default.
- Q94146087 prefLabel "ATIM-26. IMMUNOLOGIC TRENDS ASSOCIATED WITH PATIENT OUTCOMES IN A PHASE 1 CLINICAL TRIAL OF TOCA 511 AND TOCA FC IN RECURRENT HIGH GRADE GLIOMA" @default.
- Q94146087 prefLabel "ATIM-26. IMMUNOLOGIC TRENDS ASSOCIATED WITH PATIENT OUTCOMES IN A PHASE 1 CLINICAL TRIAL OF TOCA 511 AND TOCA FC IN RECURRENT HIGH GRADE GLIOMA" @default.
- Q94146087 P1433 Q94146087-4CD98D66-8001-4EE4-BC66-66F0846438BE @default.
- Q94146087 P1476 Q94146087-093C015F-07ED-48D2-A3DB-82D9B6F78517 @default.
- Q94146087 P2093 Q94146087-00292910-01E7-4F0B-91B5-71B066D8B8FD @default.
- Q94146087 P2093 Q94146087-3866A2B4-B1A4-41CC-AACE-22D6149D056E @default.
- Q94146087 P2093 Q94146087-425C151D-D1C2-4A8D-9704-170B1839CA6C @default.
- Q94146087 P2093 Q94146087-4DA7C99C-2297-42BC-83C8-ED4E0A3DD4FF @default.
- Q94146087 P2093 Q94146087-4EA64155-AC7D-4C8A-BB47-CC894D1F59FE @default.
- Q94146087 P2093 Q94146087-57F1AD00-782A-464E-8FBA-27F11A2C82EE @default.
- Q94146087 P2093 Q94146087-76B59344-6F36-4D64-8E69-26DEA9D2FE08 @default.
- Q94146087 P2093 Q94146087-7B7B5CAE-17BC-4A4A-BD13-8E191F4F4D19 @default.
- Q94146087 P2093 Q94146087-81B9737E-30D4-472B-AC07-1221B13826B3 @default.
- Q94146087 P2093 Q94146087-8CEBCEA8-7EBF-4D2E-98B9-2862F0FDD6B6 @default.
- Q94146087 P2093 Q94146087-9CDDEE07-FD6E-4CEE-86AD-86628C773A9F @default.
- Q94146087 P2093 Q94146087-BD59170A-FDD7-44CF-9511-B9499B8AF9E6 @default.
- Q94146087 P2093 Q94146087-C2404360-81E5-467C-9736-F0143AC2A946 @default.
- Q94146087 P2093 Q94146087-D43086F6-6F28-47DC-B785-AB25B3E20E37 @default.
- Q94146087 P2093 Q94146087-DD706E9F-ABAD-44F6-863A-D8CA3A4A746F @default.
- Q94146087 P2093 Q94146087-F14F9146-536C-4D0C-A04D-2A91A9546270 @default.
- Q94146087 P2093 Q94146087-FF7B00D8-EF9A-4D1A-AC2F-0D7E522B5BA7 @default.
- Q94146087 P304 Q94146087-106B994F-7809-407D-9311-0EEE62BE915C @default.
- Q94146087 P31 Q94146087-9DEE1C6A-AE2D-4EE0-A02C-0845DAF00B5F @default.
- Q94146087 P356 Q94146087-AB287932-DFAA-4F0D-959E-EBEA9E095F79 @default.
- Q94146087 P433 Q94146087-AA246122-9219-40AF-BA5E-917803742643 @default.
- Q94146087 P478 Q94146087-F377571A-691B-4105-B80C-A253A7E33E15 @default.
- Q94146087 P50 Q94146087-2B975697-5456-47AF-AC4E-2EA946141EF0 @default.
- Q94146087 P50 Q94146087-63A6AB76-D15C-4587-B417-D80833931A0F @default.
- Q94146087 P577 Q94146087-44A11604-C368-4947-B0AA-4226804BEC30 @default.
- Q94146087 P921 Q94146087-5BE675C4-7AAE-4EC8-8597-624F1EBFEF37 @default.
- Q94146087 P932 Q94146087-7C9B8E4B-AFC3-4A2F-9573-2C543936B596 @default.
- Q94146087 P356 NOY148.021 @default.
- Q94146087 P1433 Q15724471 @default.
- Q94146087 P1476 "ATIM-26. IMMUNOLOGIC TRENDS ASSOCIATED WITH PATIENT OUTCOMES IN A PHASE 1 CLINICAL TRIAL OF TOCA 511 AND TOCA FC IN RECURRENT HIGH GRADE GLIOMA" @default.
- Q94146087 P2093 "Ali Haghighi" @default.
- Q94146087 P2093 "Bob Carter" @default.
- Q94146087 P2093 "Clark Chen" @default.
- Q94146087 P2093 "Daniel Hogan" @default.
- Q94146087 P2093 "David Piccioni" @default.
- Q94146087 P2093 "Dawn Gammon" @default.
- Q94146087 P2093 "Derek Ostertag" @default.
- Q94146087 P2093 "Douglas Jolly" @default.
- Q94146087 P2093 "Harry Gruber" @default.
- Q94146087 P2093 "James Elder" @default.
- Q94146087 P2093 "Joseph Landolfi" @default.
- Q94146087 P2093 "Michael Vogelbaum" @default.
- Q94146087 P2093 "Oscar Diago" @default.
- Q94146087 P2093 "Steven Kalkanis" @default.
- Q94146087 P2093 "Thian Kheoh" @default.
- Q94146087 P2093 "Tobias Walbert" @default.
- Q94146087 P2093 "William Accomando" @default.
- Q94146087 P304 "vi6-vi7" @default.
- Q94146087 P31 Q13442814 @default.
- Q94146087 P356 "10.1093/NEUONC/NOY148.021" @default.
- Q94146087 P433 "Suppl 6" @default.
- Q94146087 P478 "20" @default.
- Q94146087 P50 Q47159504 @default.
- Q94146087 P50 Q47159896 @default.
- Q94146087 P577 "2018-11-05T00:00:00Z" @default.
- Q94146087 P921 Q5452194 @default.
- Q94146087 P932 "6216133" @default.